Australia's Starpharma rises as COVID-19 nasal spray gets sales nod in Vietnam

Starpharma Holdings

01/12/2021 24:34

** Shares of Starpharma Holdings Ltd  SPL.AX  climb as much
as 9.7% to A$1.19, set for their best day since July 27
    ** The biopharma co says it has received confirmation that
its trademark Viraleze antiviral nasal spray has been registered
for sale in Vietnam and will be launched this week  urn:newsml:reuters.com:*:nASX38yFSJ
    ** SPL had earlier signed a deal with Australian-based
Healthco Australia and Vietnam-based Truong Bao Land
International Investment for distribution in Vietnam
 urn:newsml:reuters.com:*:nASX60J6Tw
    ** Says it is finalising further distribution agreement for
additional larger orders of Viraleze in Vietnam
    ** The nasal spray, which is shown to be effective against
COVID-19, is not yet registered for sale in Australia
    ** Stock hits its highest since Nov. 25
    ** As of last close, stock down 30.7% this year

 (Reporting by Himanshi Akhand in Bengaluru)
 ((Himanshi.Akhand@thomsonreuters.com;))